These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34461113)

  • 21. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing.
    Jede C; Wagner C; Kubas H; Weber C; Weitschies W
    J Pharm Pharmacol; 2018 Oct; 70(10):1315-1323. PubMed ID: 30062721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
    J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations.
    El Sayed M; Alhalaweh A; Bergström CAS
    Mol Pharm; 2021 Nov; 18(11):4079-4089. PubMed ID: 34613730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling.
    Ruff A; Fiolka T; Kostewicz ES
    Eur J Pharm Sci; 2017 Mar; 100():42-55. PubMed ID: 28011125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Sensitivity Analysis of the Gastrointestinal Dissolution Profile of Weakly Basic Drugs in the Stomach-to-Intestine Fluid Changing System: Explanation for Variable Plasma Exposure after Oral Administration.
    Takagi T; Masada T; Minami K; Kataoka M; Izutsu KI; Matsui K; Yamashita S
    Mol Pharm; 2021 Apr; 18(4):1711-1719. PubMed ID: 33629861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated small-scale in vitro transfer model as screening tool for the prediction of in vivo-dissolution and precipitation of poorly solubles.
    Jede C; Wagner C; Kubas H; Weber C; Weigandt M; Koziolek M; Weitschies W
    Int J Pharm; 2019 Feb; 556():150-158. PubMed ID: 30553006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions.
    Enright EF; Joyce SA; Gahan CGM; Taylor LS
    Eur J Pharm Biopharm; 2020 Aug; 153():68-83. PubMed ID: 32473291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro tools for evaluating novel dosage forms of poorly soluble, weakly basic drugs: case example ketoconazole.
    Taupitz T; Dressman JB; Klein S
    J Pharm Sci; 2013 Oct; 102(10):3645-52. PubMed ID: 23873592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation.
    Gan Y; Xu Y; Zhang X; Hu H; Xiao W; Yu Z; Sun T; Zhang J; Wen C; Zheng S
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
    Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopredictive capability assessment of two dissolution/permeation assays, µFLUX™ and PermeaLoop™, using supersaturating formulations of Posaconazole.
    Holzem FL; Weck A; Schaffland JP; Stillhart C; Klein S; Bauer-Brandl A; Brandl M
    Eur J Pharm Sci; 2022 Sep; 176():106260. PubMed ID: 35842141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.
    Mann J; Dressman J; Rosenblatt K; Ashworth L; Muenster U; Frank K; Hutchins P; Williams J; Klumpp L; Wielockx K; Berben P; Augustijns P; Holm R; Hofmann M; Patel S; Beato S; Ojala K; Tomaszewska I; Bruel JL; Butler J
    Mol Pharm; 2017 Dec; 14(12):4192-4201. PubMed ID: 28737403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin.
    Ojarinta R; Heikkinen AT; Sievänen E; Laitinen R
    Eur J Pharm Biopharm; 2017 Mar; 112():85-95. PubMed ID: 27888143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
    Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
    Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.